Saratoga Health & Biotechnology Fund REGN Holdings History
Saratoga Health & Biotechnology Fund's Regeneron Pharmaceuticals Inc Holding Summary
As of 2025-02-28, Saratoga Health & Biotechnology Fund held 670.00 shares of Regeneron Pharmaceuticals Inc(REGN), totaling $468,160.00. This investment constitutes 4.48% of their stock portfolio, and Saratoga Health & Biotechnology Fund now holds 0% of the outstanding Regeneron Pharmaceuticals Inc(REGN) stock.
The initial trade took place in 2020Q3. And since then Saratoga Health & Biotechnology Fund has made 3 purchases of REGN, at an average price of $574.42, for a total of 720.00 shares. In addition, there have been 1 sales at an average price of $911.49 for 50.00 shares. Based on historical transaction data and REGN's current price of $572.39, Saratoga Health & Biotechnology Fund's estimated gain on his REGN holdings is $15,493.60, reflecting a 3.75% gain to date.
Saratoga Health & Biotechnology Fund REGN ($572.39) Holding Chart
Saratoga Health & Biotechnology Fund REGN ($572.39) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
